Treatment for chemotherapy-related arthropathy (CRA) with disease modifying antirheumatic drugs (DMARDs)
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0000160
- Lead Sponsor
- Ajou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
We enroll patients who, after starting chemotherapy, developed arthritis or arthralgia with their agreement.
Exclusion Criteria
We exclude patients who were dianosed by rheumatoid arthritis or lupus, had bone metastasis of cancer, or don't want this clinical trial.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tendor and swollen joint count;Visual analogue pain score and morning stiffness;ESR and CRP
- Secondary Outcome Measures
Name Time Method add on therapy